Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Assessment of body protein energy status in adult chronic kidney disease patients on maintainance hemodialysis.

Kotha PG, Sc R, D V.

J Assoc Physicians India. 2016 Jan;64(1):122. No abstract available.

PMID:
27728469
2.

Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune response.

Kotha PL, Sharma P, Kolawole AO, Yan R, Alghamri MS, Brockman TL, Gomez-Cambronero J, Excoffon KJ.

PLoS Pathog. 2015 Mar 13;11(3):e1004696. doi: 10.1371/journal.ppat.1004696. eCollection 2015 Mar.

3.

The PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR).

Yan R, Sharma P, Kolawole AO, Martin SC, Readler JM, Kotha PL, Hostetler HA, Excoffon KJ.

Int J Biochem Cell Biol. 2015 Apr;61:29-34. doi: 10.1016/j.biocel.2015.01.012. Epub 2015 Jan 23.

4.

Automated system for kinetic analysis of particle size distributions for pharmaceutically relevant systems.

Green JB, Carter PW, Zhang Y, Patel D, Kotha P, Gonyon T.

J Anal Methods Chem. 2014;2014:810589. doi: 10.1155/2014/810589. Epub 2014 Jul 16.

5.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

6.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

7.

Probability-based compatibility curves for calcium and phosphates in parenteral nutrition formulations.

Gonyon T, Carter PW, Phillips G, Owen H, Patel D, Kotha P, Green JB.

JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):717-27. doi: 10.1177/0148607113495415. Epub 2013 Jul 26.

PMID:
23894169
8.

Interactions between Parenteral Lipid Emulsions and Container Surfaces.

Gonyon T, Tomaso AE Jr, Kotha P, Owen H, Patel D, Carter PW, Cronin J, Green JB.

PDA J Pharm Sci Technol. 2013 May-Jun;67(3):247-54. doi: 10.5731/pdajpst.2013.00918.

PMID:
23752751
9.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

10.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators.

N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.

11.

Modified criteria for determining cardiometabolic syndrome in Asian Indians living in the USA: report from the diabetes among Indian Americans national study.

Kotha P, Patel CB, Vijayaraghavan K, Patel TG, Misra R.

Int J Cardiol. 2012 Mar 8;155(2):343-5. doi: 10.1016/j.ijcard.2011.12.040. Epub 2012 Jan 17. No abstract available.

PMID:
22261694
12.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators.

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
13.

Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.

Misra R, Patel T, Kotha P, Raji A, Ganda O, Banerji M, Shah V, Vijay K, Mudaliar S, Iyer D, Balasubramanyam A.

J Diabetes Complications. 2010 May-Jun;24(3):145-53. doi: 10.1016/j.jdiacomp.2009.01.003. Epub 2009 Mar 19.

PMID:
19303333
14.

Effect of dronedarone on cardiovascular events in atrial fibrillation.

Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators.

N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778. Erratum in: N Engl J Med. 2009 Jun 4;360(23):2487. N Engl J Med. 2011 Apr 14;364(15):1481.

15.
16.

Early deaths with thrombolytic therapy for acute myocardial infarction in corticosteroid-dependent rheumatoid arthritis.

Kotha P, McGreevy MJ, Kotha A, Look M, Weisman MH.

Clin Cardiol. 1998 Nov;21(11):853-6. Review.

17.

Liver damage induced by oxyphenisatin.

Kotha P, Rake MO, Willatt D.

Br Med J. 1980 Dec 6;281(6254):1530. No abstract available.

Supplemental Content

Loading ...
Support Center